Annual CFF
$5.97 M
+$6.08 M+5200.85%
31 March 2024
Summary:
Portage Biotech annual cash flow from financing activities is currently $5.97 million, with the most recent change of +$6.08 million (+5200.85%) on 31 March 2024. During the last 3 years, it has risen by +$1.21 million (+25.33%). PRTG annual CFF is now -78.18% below its all-time high of $27.35 million, reached on 31 March 2022.PRTG Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$8000.00
-$4000.00-100.00%
30 June 2024
Summary:
Portage Biotech quarterly cash flow from financing activities is currently -$8000.00, with the most recent change of -$4000.00 (-100.00%) on 30 June 2024. Over the past year, it has dropped by -$47.00 thousand (-120.51%). PRTG quarterly CFF is now -100.03% below its all-time high of $27.43 million, reached on 30 June 2021.PRTG Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$5.35 M
-$614.00 K-10.29%
30 June 2024
Summary:
Portage Biotech TTM cash flow from financing activities is currently $5.35 million, with the most recent change of -$614.00 thousand (-10.29%) on 30 June 2024. Over the past year, it has increased by +$1.82 million (+51.37%). PRTG TTM CFF is now -80.46% below its all-time high of $27.40 million, reached on 30 September 2021.PRTG TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTG Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5200.9% | -120.5% | +51.4% |
| 3 y3 years | +25.3% | +90.1% | -80.5% |
| 5 y5 years | +10000.0% | +92.0% | +5454.0% |
PRTG Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -78.2% | +5200.9% | -100.2% | +99.7% | -80.5% | +277.9% |
| 5 y | 5 years | -78.2% | +5200.9% | -100.0% | +99.7% | -80.5% | +277.9% |
| alltime | all time | -78.2% | +5200.9% | -100.0% | +99.9% | -80.5% | +186.9% |
Portage Biotech Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$8000.00(+100.0%) | $5.35 M(-10.3%) |
| Mar 2024 | $5.97 M(-5200.9%) | -$4000.00(-100.1%) | $5.97 M(-26.3%) |
| Dec 2023 | - | $5.33 M(>+9900.0%) | $8.09 M(+128.8%) |
| Sept 2023 | - | $39.00 K(-93.6%) | $3.54 M(+623.3%) |
| June 2023 | - | $606.00 K(-71.4%) | $489.00 K(-517.9%) |
| Mar 2023 | -$117.00 K(-100.4%) | $2.12 M(+175.6%) | -$117.00 K(-94.8%) |
| Dec 2022 | - | $770.00 K(-125.6%) | -$2.24 M(-25.6%) |
| Sept 2022 | - | -$3.01 M(<-9900.0%) | -$3.01 M(+3614.8%) |
| June 2022 | - | $0.00(0.0%) | -$81.00 K(-100.3%) |
| Mar 2022 | $27.35 M(+474.3%) | $0.00(0.0%) | $27.35 M(-0.2%) |
| Dec 2021 | - | $0.00(-100.0%) | $27.40 M(0.0%) |
| Sept 2021 | - | -$81.00 K(-100.3%) | $27.40 M(+7.6%) |
| June 2021 | - | $27.43 M(>+9900.0%) | $25.46 M(+434.6%) |
| Mar 2021 | $4.76 M(+580.3%) | $50.00 K(>+9900.0%) | $4.76 M(-16.6%) |
| Dec 2020 | - | $0.00(-100.0%) | $5.71 M(+3.6%) |
| Sept 2020 | - | -$2.02 M(-130.0%) | $5.51 M(-25.8%) |
| June 2020 | - | $6.73 M(+573.2%) | $7.43 M(+961.7%) |
| Mar 2020 | $700.00 K(-1500.0%) | $1.00 M(-600.0%) | $700.00 K(-333.3%) |
| Dec 2019 | - | -$200.00 K(+100.0%) | -$300.00 K(+200.0%) |
| Sept 2019 | - | -$100.00 K(<-9900.0%) | -$100.00 K(+100.0%) |
| June 2019 | - | $0.00(0.0%) | -$50.00 K(0.0%) |
| Mar 2019 | -$50.00 K(-101.8%) | $0.00(0.0%) | -$50.00 K(+2.0%) |
| Dec 2018 | - | $0.00(-100.0%) | -$49.00 K(-102.2%) |
| Sept 2018 | - | -$50.00 K(-5100.0%) | $2.19 M(-21.1%) |
| Mar 2018 | $2.78 M(+1288.0%) | $1000.00(-100.0%) | $2.78 M(-6.7%) |
| Dec 2017 | - | $2.24 M(>+9900.0%) | $2.98 M(+304.2%) |
| Sept 2017 | - | $0.00(-100.0%) | $736.00 K(-111.9%) |
| June 2017 | - | $536.00 K(+168.0%) | -$6.16 M(-3181.6%) |
| Mar 2017 | $200.00 K(-98.1%) | $200.00 K(>+9900.0%) | $200.00 K(-93.3%) |
| Dec 2016 | - | $0.00(-100.0%) | $3.00 M(-20.0%) |
| Sept 2016 | - | -$6.90 M(-200.0%) | $3.75 M(-69.4%) |
| June 2016 | - | $6.90 M(+129.8%) | $12.25 M(+16.6%) |
| Mar 2016 | $10.51 M(+357.0%) | $3.00 M(+299.2%) | $10.51 M(+40.0%) |
| Dec 2015 | - | $752.00 K(-53.0%) | $7.51 M(-12.2%) |
| Sept 2015 | - | $1.60 M(-68.9%) | $8.55 M(+14.7%) |
| June 2015 | - | $5.16 M(>+9900.0%) | $7.46 M(+224.1%) |
| Mar 2015 | $2.30 M(-39.1%) | $0.00(-100.0%) | $2.30 M(-6.2%) |
| Dec 2014 | - | $1.79 M(+255.4%) | $2.45 M(+273.0%) |
| Sept 2014 | - | $505.00 K(>+9900.0%) | $657.60 K(+1215.2%) |
| June 2014 | - | $0.00(-100.0%) | $50.00 K(-98.7%) |
| Mar 2014 | $3.78 M(>+9900.0%) | $152.60 K(>+9900.0%) | $3.78 M(+4.2%) |
| Dec 2013 | - | $0.00(-100.0%) | $3.62 M(0.0%) |
| Sept 2013 | - | -$102.60 K(-102.8%) | $3.62 M(-2.8%) |
| June 2013 | - | $3.73 M(>+9900.0%) | $3.73 M(>+9900.0%) |
| Mar 2013 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2011 | - | $0.00(0.0%) | -$850.00 K(+1.9%) |
| June 2011 | - | $0.00(-100.0%) | -$833.80 K(+892.6%) |
| Mar 2011 | -$84.00 K(-101.3%) | -$909.80 K(-1621.4%) | -$84.00 K(-102.3%) |
| Dec 2010 | - | $59.80 K(+269.1%) | $3.72 M(-48.8%) |
| Sept 2010 | - | $16.20 K(-97.8%) | $7.27 M(-0.7%) |
| June 2010 | - | $749.80 K(-74.1%) | $7.32 M(+11.4%) |
| Mar 2010 | $6.57 M(>+9900.0%) | $2.89 M(-19.9%) | $6.57 M(+76.5%) |
| Dec 2009 | - | $3.61 M(+5084.5%) | $3.72 M(+3165.3%) |
| Sept 2009 | - | $69.60 K(>+9900.0%) | $114.00 K(+156.8%) |
| June 2009 | - | $0.00(-100.0%) | $44.40 K(0.0%) |
| Mar 2009 | $44.40 K(-58.5%) | $44.40 K(>+9900.0%) | $44.40 K(-1157.1%) |
| Dec 2008 | - | $0.00(0.0%) | -$4200.00(+7.7%) |
| Sept 2008 | - | $0.00(-100.0%) | -$3900.00(-103.6%) |
| Mar 2008 | $107.10 K(-89.5%) | -$4200.00(-1500.0%) | $107.10 K(-12.1%) |
| Dec 2007 | - | $300.00(-96.0%) | $121.80 K(+57.2%) |
| Sept 2007 | - | $7500.00(-92.8%) | $77.50 K(+14.5%) |
| June 2007 | - | $103.50 K(+885.7%) | $67.70 K(-93.3%) |
| Mar 2007 | $1.02 M(-69.3%) | $10.50 K(-123.9%) | $1.02 M(-56.1%) |
| Dec 2006 | - | -$44.00 K(+1813.0%) | $2.32 M(-9.0%) |
| Sept 2006 | - | -$2300.00(-100.2%) | $2.55 M(-34.8%) |
| June 2006 | - | $1.05 M(-19.7%) | $3.91 M(+18.1%) |
| Mar 2006 | $3.31 M(+26.3%) | $1.31 M(+612.6%) | $3.31 M(+65.7%) |
| Dec 2005 | - | $184.00 K(-86.5%) | $2.00 M(-6.5%) |
| Sept 2005 | - | $1.36 M(+199.8%) | $2.13 M(+172.7%) |
| June 2005 | - | $453.10 K(+40.7%) | $782.20 K(-39.0%) |
| Dec 2004 | - | $322.00 K(+4435.2%) | $1.28 M(-6.3%) |
| Sept 2004 | - | $7100.00(-94.5%) | $1.37 M(-40.5%) |
| June 2004 | - | $128.10 K(-84.5%) | $2.30 M(-12.1%) |
| Mar 2004 | $2.62 M(+2679.1%) | $825.90 K(+102.3%) | $2.62 M(+45.2%) |
| Dec 2003 | - | $408.20 K(-56.5%) | $1.80 M(+27.4%) |
| Sept 2003 | - | $938.30 K(+110.6%) | $1.42 M(+170.3%) |
| June 2003 | - | $445.50 K(+3842.5%) | $523.70 K(+455.9%) |
| Mar 2003 | $94.20 K(-31.9%) | $11.30 K(-45.1%) | $94.20 K(-40.2%) |
| Dec 2002 | - | $20.60 K(-55.5%) | $157.40 K(-16.5%) |
| Sept 2002 | - | $46.30 K(+189.4%) | $188.50 K(+26.0%) |
| June 2002 | - | $16.00 K(-78.5%) | $149.60 K(+8.2%) |
| Mar 2002 | $138.30 K(-222.4%) | $74.50 K(+44.1%) | $138.30 K(+116.8%) |
| Dec 2001 | - | $51.70 K(+598.6%) | $63.80 K(+427.3%) |
| Sept 2001 | - | $7400.00(+57.4%) | $12.10 K(+157.4%) |
| June 2001 | - | $4700.00 | $4700.00 |
| Mar 2001 | -$113.00 K(-104.4%) | - | - |
| Mar 2000 | $2.56 M(+502.7%) | - | - |
| Mar 1999 | $425.40 K(+3.7%) | - | - |
| Mar 1998 | $410.20 K | - | - |
FAQ
- What is Portage Biotech annual cash flow from financing activities?
- What is the all time high annual CFF for Portage Biotech?
- What is Portage Biotech annual CFF year-on-year change?
- What is Portage Biotech quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Portage Biotech?
- What is Portage Biotech quarterly CFF year-on-year change?
- What is Portage Biotech TTM cash flow from financing activities?
- What is the all time high TTM CFF for Portage Biotech?
- What is Portage Biotech TTM CFF year-on-year change?
What is Portage Biotech annual cash flow from financing activities?
The current annual CFF of PRTG is $5.97 M
What is the all time high annual CFF for Portage Biotech?
Portage Biotech all-time high annual cash flow from financing activities is $27.35 M
What is Portage Biotech annual CFF year-on-year change?
Over the past year, PRTG annual cash flow from financing activities has changed by +$6.08 M (+5200.85%)
What is Portage Biotech quarterly cash flow from financing activities?
The current quarterly CFF of PRTG is -$8000.00
What is the all time high quarterly CFF for Portage Biotech?
Portage Biotech all-time high quarterly cash flow from financing activities is $27.43 M
What is Portage Biotech quarterly CFF year-on-year change?
Over the past year, PRTG quarterly cash flow from financing activities has changed by -$47.00 K (-120.51%)
What is Portage Biotech TTM cash flow from financing activities?
The current TTM CFF of PRTG is $5.35 M
What is the all time high TTM CFF for Portage Biotech?
Portage Biotech all-time high TTM cash flow from financing activities is $27.40 M
What is Portage Biotech TTM CFF year-on-year change?
Over the past year, PRTG TTM cash flow from financing activities has changed by +$1.82 M (+51.37%)